Commodore Capital
Venture capitalNew York · Series C–Late Stage · 2 people tracked
Investment thesis
Commodore Capital invests in late-stage private and small-cap public biopharmaceutical companies. The firm focuses on medical product development in healthcare.
Team · 2 people
from the firm's websiteFrequently asked questions
- What stage does Commodore Capital invest at?
- Commodore Capital invests at the Series C, Late Stage stages.
- What sectors does Commodore Capital focus on?
- Commodore Capital focuses on Biotech.
- Where is Commodore Capital located?
- Commodore Capital is headquartered in New York, US.
Similar investors
Summit Partners is a growth-focused investment firm with over 41 years of experience investing in category-leading companies across technology, healthcare and life sciences, and growth products and services. The firm leverages a collaborative approach to support market leaders through both minority and majority investments.
The Novartis Venture Fund invests in biotechnology and biopharmaceutical companies at various stages of development to foster innovation and drive patient benefit while generating superior returns.
Pappas Capital has invested in over 100 life science companies across the United States, Canada, and Asia for three decades. The firm focuses on developing innovative medical products and technologies to treat various human diseases.
OrbiMed is a global healthcare investment firm with over 25 years of experience investing across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.